Concepedia

Robert A.B. van Waterschoot

RA

16

Publications

1.2K

Citations

15

H-Index

2006

Active since

Affiliations

The Netherlands Cancer Institute(Current)

Slotervaartziekenhuis

Oncode Institute

Utrecht University

Robert A.B. van Waterschoot is an author at The Netherlands Cancer Institute specializing in medicine, pharmacology, and metabolomics.

Top concepts

Publications per year

2006–2014

16

Publications

16

Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism

Antonius E. van Herwaarden, Els Wagenaar, Cornelia M.M. van der Kruijssen et al. · Journal of Clinical Investigation · 2007 · 234 citations · Full text

Breast Cancer Resistance Protein and P-glycoprotein Limit Sorafenib Brain Accumulation

Jurjen S. Lagas, Robert A.B. van Waterschoot, Rolf W. Sparidans et al. · Molecular Cancer Therapeutics · 2010 · 180 citations

Brain Accumulation of Dasatinib Is Restricted by P-Glycoprotein (ABCB1) and Breast Cancer Resistance Protein (ABCG2) and Can Be Enhanced by Elacridar Treatment

Jurjen S. Lagas, Robert A.B. van Waterschoot, Vicky A.C.J. van Tilburg et al. · Clinical Cancer Research · 2009 · 171 citations

Midazolam Metabolism in Cytochrome P450 3A Knockout Mice Can Be Attributed to Up-Regulated CYP2C Enzymes

Robert A.B. van Waterschoot, Antonius E. van Herwaarden, Jurjen S. Lagas et al. · Molecular Pharmacology · 2007 · 110 citations · Full text

Absence of Both Cytochrome <i>P</i> 450 3A and P-glycoprotein Dramatically Increases Docetaxel Oral Bioavailability and Risk of Intestinal Toxicity

Robert A.B. van Waterschoot, Jurjen S. Lagas, Els Wagenaar et al. · Cancer Research · 2009 · 97 citations

Rows per page

1–5 of 16